The Interventional Consumable Market is highly competitive, characterized by frequent mergers, acquisitions, and strategic partnerships. Large medical technology companies are continually looking to acquire niche players that hold proprietary technology, particularly in areas like structural heart disease or neuro-intervention. These collaborations allow established firms to expand their...